Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

mutation

  • You have access
    PIK3CA Mutations as a Prognostic Factor in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy
    JUNGSUP BYUN, NORA JEE-YOUNG PARK, GHILSUK YOON, MIN KYU KANG, HYE JIN KIM, SOO YEUN PARK, JUN SEOK PARK, GYU SEOG CHOI, JIN HO BAEK, JONG GWANG KIM and AN NA SEO
    Anticancer Research April 2023, 43 (4) 1513-1520; DOI: https://doi.org/10.21873/anticanres.16300
  • You have access
    A Clinicopathological Study of Young-onset Hepatocellular Carcinoma
    KWAN-YUNG AU, KRISTY KWAN-SHUEN CHAN and REGINA CHEUK-LAM LO
    Anticancer Research June 2021, 41 (6) 2933-2944; DOI: https://doi.org/10.21873/anticanres.15075
  • You have access
    Discovery of a Novel Chemical Scaffold Against Mutant Isocitrate Dehydrogenase 1 (IDH1)
    CHUNG HYO KANG, SANG UN CHOI, YOU HWA SON, HEUNG KYOUNG LEE, HYE GWANG JEONG, CHANG-SOO YUN, SUNJOO AHN and CHI HOON PARK
    Anticancer Research September 2020, 40 (9) 4929-4935; DOI: https://doi.org/10.21873/anticanres.14496
  • You have access
    Separating Response of Tumor and non-Tumor Cells to Drug In Vitro by Quantifying a Mutation
    MARKUS KLEINPOPPEN, CHRISTOPH MOEBIUS, KATHARINA GRUPP, LAN KLUWE and MARCO BLESSMANN
    Anticancer Research April 2019, 39 (4) 1777-1783; DOI: https://doi.org/10.21873/anticanres.13284
  • You have access
    Identification of Two Types of Stem Cells in Methylene Blue-stained Sections of Untreated and Diethylstilbestrol-treated Human Prostate Cancer and Their Characterization by Immunogold Localization of CD133
    AKHOURI A. SINHA and MICHAEL J. WILSON
    Anticancer Research October 2018, 38 (10) 5725-5732; DOI: https://doi.org/10.21873/anticanres.12910
  • You have access
    Frequency of the Loss of Heterozygosity of the NF2 Gene in Sporadic Spinal Schwannomas
    RAIMUNDO MIRANDA DE CARVALHO, CARLA DE CASTRO SANT' ANNA, GIOVANNY REBOUÇAS PINTO, ERIC HOMERO ALBUQUERQUE PASCHOAL, FABRICIO MESQUITA TUJI, BARBARA DO NASCIMENTO BORGES, PAULO CARDOSO SOARES, ALBERTO GOMES FERREIRA JÚNIOR, JUAN ANTONIO REY, LUIZ CLÁUDIO LOPES CHAVES and ROMMEL RODRIGUEZ BURBANO
    Anticancer Research April 2018, 38 (4) 2149-2154;
  • You have access
    CTNNB1 Mutations in Ovarian Microcystic Stromal Tumors: Identification of a Novel Deletion Mutation and the Use of Pyrosequencing to Identify Reported Point Mutation
    KIYONG NA, EUN KYUNG KIM, WONJUN JANG and HYUN-SOO KIM
    Anticancer Research June 2017, 37 (6) 3249-3258;
  • You have access
    Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas
    DEMETRIOS MORIS, CHRISTOS DAMASKOS, ELEFTHERIOS SPARTALIS, ALEXANDROS PAPALAMPROS, SPYRIDON VERNADAKIS, DIMITRIOS DIMITROULIS, JOHN GRINIATSOS, EVANGELOS FELEKOURAS and NIKOLAOS NIKITEAS
    Anticancer Research May 2017, 37 (5) 2185-2194;
  • You have access
    Prognostic Impact of EGFR Driver Mutations on Postoperative Disease Recurrence in Lung Adenocarcinoma
    TATSURO OKAMOTO, HIROKAZU KITAHARA, SHINICHIRO SHIMAMATSU, MASAKAZU KATSURA, KAZUKI TAKADA, TAKATOSHI FUJISHITA, YUZO SUZUKI, YOSUKE MORODOMI, TETSUZO TAGAWA and YOSHIHIKO MAEHARA
    Anticancer Research June 2016, 36 (6) 3057-3063;
  • You have access
    Patients with Non-small Cell Lung Cancer Analyzed for EGFR: Adherence to Guidelines, Prevalence and Outcome
    MARTIN SANDELIN, ANDERS BERGLUND, MAGNUS SUNDSTRÖM, PATRICK MICKE, SIMON EKMAN, MICHAEL BERGQVIST, STEFAN BERGSTRÖM, HIRSH KOYI, EVA BRANDÉN, CHRISTER JANSON and JOHAN BOTLING
    Anticancer Research July 2015, 35 (7) 3979-3985;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire